Thoracic mesenchymal malignant tumors and programed cell death ligand‐1 status: Clinicopathologic and prognostic analysis of eight pulmonary sarcomatoid carcinomas and eight malignant mesotheliomas

BACKGROUND: The current study aimed to evaluate the significance of clinicopathological factors, particularly the immunohistochemistry of programed cell death ligand‐1 (PD‐L1), in eight cases each of pulmonary sarcomatoid carcinoma (PSC) and malignant pleural mesothelioma (MPM) at our hospital. METH...

Descripción completa

Detalles Bibliográficos
Autores principales: Otsubo, Kanji, Sakai, Hiroki, Kimura, Hiroyuki, Miyazawa, Tomoyuki, Marushima, Hideki, Kojima, Koji, Furuya, Naoki, Mineshita, Masamichi, Chosokabe, Motohiro, Koike, Junki, Saji, Hisashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8636199/
https://www.ncbi.nlm.nih.gov/pubmed/34655161
http://dx.doi.org/10.1111/1759-7714.14177

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8636199/
https://www.ncbi.nlm.nih.gov/pubmed/34655161
http://dx.doi.org/10.1111/1759-7714.14177

Ejemplares similares